| トルコ | オーストリア | スペイン | |
| 大腸癌に対する放射線療法 | から $7,000 | から $12,000 | から $10,000 |
| 乳癌化学療法 | から $1,200 | から $15,000 | から $3,500 |
| 乳癌に対する免疫療法 | から $9,500 | から $35,000 | から $45,000 |
| 乳房腫瘍摘出術 | から $2,700 | から $8,500 | から $4,500 |
| 乳房切除術 | から $4,500 | から $10,000 | から $8,000 |
Dr. Aleix Prat is a clinical scientist with expertise in breast cancer research, gene expression, and clinical trials. He earned his MD from the University of Barcelona. He completed his oncology fellowship at Vall d’Hebron Institute of Oncology. Dr. Prat leads the Translational Genomics and Targeted Therapeutics in Solid Tumors Group at IDIBAPS. He is also President of SOLTI and serves on the Executive Committee of The Breast International Group.
Dr. Prat has published over 160 scientific papers. His work has received 13,479 citations, and he has an H-Index of 51. He is a Tenure-Track Professor at the University of Barcelona. He also directs the Breast Pathology–Senology Master’s degree. His roles highlight his strong academic and clinical contributions to oncology.